Login to Your Account



News from Washington


Monday, July 14, 2014
Two members of the Senate Finance committee sent a letter to Foster City, Calif.-based Gilead Sciences Inc. questioning the price tag for hepatitis C virus (HCV) drug Sovaldi (sofosbuvir), which costs more than $80,000 for a course of treatment – about $1,000 per pill.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription